Prostate Cancer - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Vaccine Therapy for Patients with Progressive Stage D0 Prostate Cancer
(Posted: 03/23/2010) - In this phase I trial, researchers are evaluating the safety of a vaccine to treat stage D0 prostate cancer and whether the body’s immune system will respond to it by producing T lymphocytes that will selectively attack cancer cells.
- Pomegranate Juice for PSA-only Prostate Cancer Recurrence
(Posted: 09/25/2007, Updated: 03/16/2010) - In this clinical trial, researchers are exploring the potential of pomegranate juice to slow or reverse increasing PSA levels in men who have undergone treatment for localized prostate cancer.
- Sorafenib for Metastatic Prostate Cancer
(Posted: 01/23/2007, Updated: 02/09/2010) - In this clinical trial, patients with metastatic, androgen-independent prostate cancer will be treated with sorafenib, a small-molecule inhibitor that blocks the activity of several cancer-related proteins.
- Testing Satraplatin in Advanced Prostate Cancer
(Posted: 10/20/2009) - In this clinical trial, men with androgen-independent metastatic prostate cancer that has progressed after first-line chemotherapy will be treated with satraplatin and prednisone.
- Imaging the Extent of Prostate Cancer
(Posted: 06/02/2009, Updated: 07/31/2009) - In this clinical trial, researchers are testing PET scans using carbon-11 (C-11) acetate in conjunction with subsequent MRI to see if the resulting images allow better characterization of both the physical extent and the relative level of cellular growth of prostate tumors in patients known to have prostate cancer.